Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07251712
PHASE1
Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet
Sponsor: Galmed Pharmaceuticals Ltd
View on ClinicalTrials.gov
Summary
Evaluate the exposure of of Aramchol from 2 different single doses of Aramchol meglumine tablet and to compare the exposure of steady state from a selected dose of Aramchol meglumine tablet.
Official title: A Phase I Open-label Trial in Healthy Volunteers to Evaluate the Exposure of Aramchol From Two Different Single Doses of an Aramchol Meglumine Tablet
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2025-12-25
Completion Date
2026-05-15
Last Updated
2026-03-17
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Aramchol
Aramchol tablet at 2 different single doses
Locations (1)
Hammersmith Medicines Research (HMR)
London, United Kingdom